ADCT is expected to report earnings to rise+43% to -55 cents per share on May 06

A.I.dvisor
at Tickeron.com
05/05/24
Loading...
ADCT - ADC Therapeutics SA
ADC Therapeutics SA Earnings Graph
Q1'24
Est.
$-0.55
Q4'23
Missed
by $0.51
Q3'23
Beat
by $0.23
Q2'23
Beat
by $0.12
Q1'23
Missed
by $0.57
The last earnings report on December 31 showed earnings per share of -97 cents, missing the estimate of -46 cents. P/B Ratio (0.000) is normal, around the industry mean (10.284). P/E Ratio (0.000) is within average values for comparable stocks, (116.129). ADCT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.466). ADCT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (5.757) is also within normal values, averaging (233.049). With 323.27K shares outstanding, the current market capitalization sits at 405.79M.
View a ticker or compare two or three
ADCTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com